Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Cash from Operations (2018 - 2025)

Exagen (XGN) has disclosed Cash from Operations for 8 consecutive years, with 3013000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 930.03% year-over-year to 3013000.0, compared with a TTM value of 13625000.0 through Dec 2025, down 2.61%, and an annual FY2025 reading of 13625000.0, down 2.61% over the prior year.
  • Cash from Operations was 3013000.0 for Q4 2025 at Exagen, down from 2944000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 8349000.0 in Q4 2023 and bottomed at 11154000.0 in Q2 2022.
  • Average Cash from Operations over 5 years is 4688950.0, with a median of 4955000.0 recorded in 2021.
  • The sharpest move saw Cash from Operations skyrocketed 245.61% in 2023, then tumbled 930.03% in 2025.
  • Year by year, Cash from Operations stood at 6047000.0 in 2021, then grew by 5.18% to 5734000.0 in 2022, then surged by 245.61% to 8349000.0 in 2023, then plummeted by 95.65% to 363000.0 in 2024, then crashed by 930.03% to 3013000.0 in 2025.
  • Business Quant data shows Cash from Operations for XGN at 3013000.0 in Q4 2025, 2944000.0 in Q3 2025, and 2885000.0 in Q2 2025.